EXTL2 (Exostosin Like Glycosyltransferase 2) is a Protein Coding gene. Diseases associated with EXTL2 include Hereditary Multiple Exostoses and Breast Pericanalicular Fibroadenoma. Among its related pathways are heparan sulfate biosynthesis and Metabolism. An important paralog of this gene is EXTL3.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the EXTL2 Antibody industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Above 90%
Above 95%
Above 99%
Others
Market Segment by Product Application
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others
Finally, the report provides detailed profile and data information analysis of leading company.
R&D Systems(US)
Novus Biologicals(US)
Biosave(UK)
Abcam(UK)
BosterBio(US)
Thermo Fisher Scientific(US)
Proteintech(US)
Atlas Antibodies(SE)
Funakoshi(JP)
RayBiotech, Inc.(US)
Santa Cruz Biotechnology(US)
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global EXTL2 Antibody consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of EXTL2 Antibody market by identifying its various subsegments.
3.Focuses on the key global EXTL2 Antibody manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the EXTL2 Antibody with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of EXTL2 Antibody submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global EXTL2 Antibody Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 EXTL2 Antibody Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 EXTL2 Antibody Segment by Type
2.1.1 Above 90%
2.1.2 Above 95%
2.1.3 Above 99%
2.1.4 Others
2.2 Market Analysis by Application
2.2.1 Biopharmaceutical Companies
2.2.2 Hospitals
2.2.3 Bioscience Research Institutions
2.2.4 Others
2.3 Global EXTL2 Antibody Market Comparison by Regions (2017-2027)
2.3.1 Global EXTL2 Antibody Market Size (2017-2027)
2.3.2 North America EXTL2 Antibody Status and Prospect (2017-2027)
2.3.3 Europe EXTL2 Antibody Status and Prospect (2017-2027)
2.3.4 China EXTL2 Antibody Status and Prospect (2017-2027)
2.3.5 Japan EXTL2 Antibody Status and Prospect (2017-2027)
2.3.6 Southeast Asia EXTL2 Antibody Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): EXTL2 Antibody Industry Impact
2.5.1 EXTL2 Antibody Business Impact Assessment - Covid-19
2.5.2 Market Trends and EXTL2 Antibody Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global EXTL2 Antibody Sales and Market Share by Manufacturer (2017-2022)
3.2 Global EXTL2 Antibody Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global EXTL2 Antibody Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 EXTL2 Antibody Manufacturer Market Share
3.5 Top 10 EXTL2 Antibody Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into EXTL2 Antibody Market
3.7 Key Manufacturers EXTL2 Antibody Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of EXTL2 Antibody Industry Key Manufacturers
4.1 R&D Systems(US)
4.1.1 Compan Detail
4.1.2 R&D Systems(US) EXTL2 Antibody Product Introduction, Application and Specification
4.1.3 R&D Systems(US) 163 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 R&D Systems(US) News
4.2 Novus Biologicals(US)
4.2.1 Compan Detail
4.2.2 Novus Biologicals(US) EXTL2 Antibody Product Introduction, Application and Specification
4.2.3 Novus Biologicals(US) EXTL2 Antibody Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 R&D Systems(US) News
4.3 Biosave(UK)
4.3.1 Compan Detail
4.3.2 Biosave(UK) EXTL2 Antibody Product Introduction, Application and Specification
4.3.3 Biosave(UK) EXTL2 Antibody Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Biosave(UK) News
4.4 Abcam(UK)
4.4.1 Compan Detail
4.4.2 Abcam(UK) EXTL2 Antibody Product Introduction, Application and Specification
4.4.3 Abcam(UK) EXTL2 Antibody Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Abcam(UK) News
4.5 BosterBio(US)
4.5.1 Compan Detail
4.5.2 Abcam(UK) EXTL2 Antibody Product Introduction, Application and Specification
4.5.3 BosterBio(US) EXTL2 Antibody Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 BosterBio(US) News
4.6 Thermo Fisher Scientific(US)
4.6.1 Compan Detail
4.6.2 Thermo Fisher Scientific(US) EXTL2 Antibody Product Introduction, Application and Specification
4.6.3 Thermo Fisher Scientific(US) EXTL2 Antibody Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Thermo Fisher Scientific(US) News
4.7 Proteintech(US)
4.7.1 Compan Detail
4.7.2 Proteintech(US) EXTL2 Antibody Product Introduction, Application and Specification
4.7.3 Proteintech(US) EXTL2 Antibody Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Atlas Antibodies(SE)
4.8.1 Compan Detail
4.8.2 Atlas Antibodies(SE) EXTL2 Antibody Product Introduction, Application and Specification
4.8.3 Atlas Antibodies(SE) EXTL2 Antibody Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Atlas Antibodies(SE) News
4.9 Funakoshi(JP)
4.9.1 Compan Detail
4.9.2 Funakoshi(JP) EXTL2 Antibody Product Introduction, Application and Specification
4.9.3 Funakoshi(JP) EXTL2 Antibody Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Funakoshi(JP) News
4.10 RayBiotech, Inc.(US)
4.10.1 Compan Detail
4.10.2 RayBiotech, Inc.(US) EXTL2 Antibody Product Introduction, Application and Specification
4.10.3 RayBiotech, Inc.(US) EXTL2 Antibody Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 RayBiotech, Inc.(US) News
4.11 Santa Cruz Biotechnology(US)
4.11.1 Compan Detail
4.11.2 Santa Cruz Biotechnology(US) EXTL2 Antibody Product Introduction, Application and Specification
4.11.3 Santa Cruz Biotechnology(US) EXTL2 Antibody Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Santa Cruz Biotechnology(US) News
5 Global EXTL2 Antibody Market Segment by Big Type
5.1 Global EXTL2 Antibody Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global EXTL2 Antibody Sales and Market Share by Big Type (2017-2022)
5.1.2 Global EXTL2 Antibody Revenue and Market Share by Big Type (2017-2022)
5.2 Above 90% Sales Growth Rate and Price
5.2.1 Global Above 90% Sales Growth Rate (2017-2022)
5.2.2 Global Above 90% Price (2017-2022)
5.3 Above 95% Sales Growth Rate and Price
5.3.1 Global Above 95% Sales Growth Rate (2017-2022)
5.3.2 Global Above 95% Price (2017-2022)
5.4 Above 99% Sales Growth Rate and Price
5.4.1 Global Above 99% Sales Growth Rate (2017-2022)
5.4.2 Global Above 99% Price (2017-2022)
5.5 Others Sales Growth Rate and Price
5.5.1 Global Others Sales Growth Rate (2017-2022)
5.5.2 Global Others Price (2017-2022)
6 Global EXTL2 Antibody Market Segment by Big Application
6.1 Global EXTL2 Antibody Sales Market Share by Big Application (2017-2022)
6.2 Biopharmaceutical Companies Sales Growth Rate (2017-2022)
6.3 Hospitals Sales Growth Rate (2017-2022)
6.4 Bioscience Research Institutions Sales Growth Rate (2017-2022)
6.5 Others Sales Growth Rate (2017-2022)
7 Global EXTL2 Antibody Forecast
7.1 Global EXTL2 Antibody Revenue, Sales and Growth Rate (2022-2027)
7.2 EXTL2 Antibody Market Forecast by Regions (2022-2027)
7.2.1 North America EXTL2 Antibody Market Forecast (2022-2027)
7.2.2 Europe EXTL2 Antibody Market Forecast (2022-2027)
7.2.3 China EXTL2 Antibody Market Forecast (2022-2027)
7.2.4 Japan EXTL2 Antibody Market Forecast (2022-2027)
7.2.5 Southeast Asia EXTL2 Antibody Market Forecast (2022-2027)
7.2.6 Other Regions EXTL2 Antibody Market Forecast (2022-2027)
7.3 EXTL2 Antibody Market Forecast by Type (2022-2027)
7.3.1 Global EXTL2 Antibody Sales Forecast by Type (2022-2027)
7.3.2 Global EXTL2 Antibody Market Share Forecast by Type (2022-2027)
7.4 EXTL2 Antibody Market Forecast by Application (2022-2027)
7.4.1 Global EXTL2 Antibody Sales Forecast by Application (2022-2027)
7.4.2 Global EXTL2 Antibody Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 EXTL2 Antibody Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 EXTL2 Antibody Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture EXTL2 Antibody
Figure Market Concentration Ratio and Market Maturity Analysis of EXTL2 Antibody
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global EXTL2 Antibody Market Size by Big Type
Figure Global Market Share of EXTL2 Antibody by Big Type in 2021
Figure Above 90% Picture (2017-2022)
Figure Above 95% Picture (2017-2022)
Figure Above 99% Picture (2017-2022)
Global EXTL2 Antibody Market Size by Big Application
Table Global EXTL2 Antibody Market Size by Application
Figure Global EXTL2 Antibody Market Share by Big Application in 2021
Figure Biopharmaceutical Companies Picture
Figure Hospitals Picture
Figure Bioscience Research Institutions Picture
Figure Others Picture
Table Global EXTL2 Antibody Comparison by Regions (M USD) (2017-2027?
Figure Global EXTL2 Antibody Market Size (Million US$) (2017-2027)
Figure North America EXTL2 Antibody Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe EXTL2 Antibody Revenue (Million US$) Growth Rate (2017-2027)
Figure China EXTL2 Antibody Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan EXTL2 Antibody Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia EXTL2 Antibody Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and EXTL2 Antibody Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global EXTL2 Antibody Sales by Manufacturer (2017-2022)
Figure Global EXTL2 Antibody Sales Market Share by Manufacturer in 2021
Table Global EXTL2 Antibody Revenue by Manufacturer (2017-2022)
Figure Global EXTL2 Antibody Revenue Market Share by Manufacturer in 2021
Table Global EXTL2 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 EXTL2 Antibody Manufacturer (Revenue) Market Share in 2021
Figure Top 10 EXTL2 Antibody Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into EXTL2 Antibody Market
Table Key Manufacturers EXTL2 Antibody Product Type
Table Mergers & Acquisitions Planning
Table R&D Systems(US) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of R&D Systems(US)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Novus Biologicals(US) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of Novus Biologicals(US)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novus Biologicals(US) Recent Development
Table Biosave(UK) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of Biosave(UK)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biosave(UK) Main Business
Table Biosave(UK) Recent Development
Table Abcam(UK) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of Abcam(UK)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Abcam(UK) Main Business
Table Abcam(UK) Recent Development
Table Abcam(UK) Main Business
Table Abcam(UK) Recent Development
Table BosterBio(US) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of BosterBio(US)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table BosterBio(US) Main Business
Table BosterBio(US) Recent Development
Table Thermo Fisher Scientific(US) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of Thermo Fisher Scientific(US)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Thermo Fisher Scientific(US) Main Business
Table Thermo Fisher Scientific(US) Recent Development
Table Proteintech(US) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of Proteintech(US)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Proteintech(US) Main Business
Table Proteintech(US) Recent Development
Table Atlas Antibodies(SE) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of Atlas Antibodies(SE)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Atlas Antibodies(SE) Main Business
Table Atlas Antibodies(SE) Recent Development
Table Funakoshi(JP) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of Funakoshi(JP)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Funakoshi(JP) Main Business
Table Funakoshi(JP) Recent Development
Table RayBiotech, Inc.(US) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of RayBiotech, Inc.(US)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table RayBiotech, Inc.(US) Main Business
Table RayBiotech, Inc.(US) Recent Development
Table Santa Cruz Biotechnology(US) Company Profile
Table EXTL2 Antibody Product Introduction, Application and Specification of Santa Cruz Biotechnology(US)
Table EXTL2 Antibody Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Santa Cruz Biotechnology(US) Main Business
Table Santa Cruz Biotechnology(US) Recent Development
Figure Global EXTL2 Antibody Sales and Growth Rate (2017-2022)
Figure Global EXTL2 Antibody Revenue and Growth Rate (2017-2022)
Table Global EXTL2 Antibody Sales by Regions (2017-2022)
Figure Global EXTL2 Antibody Sales Market Share by Regions in 2021
Table Global EXTL2 Antibody Revenue by Regions (2017-2022)
Figure Global EXTL2 Antibody Revenue Market Share by Regions in 2021
Figure North America EXTL2 Antibody Sales and Growth Rate (2017-2022)
Figure Europe EXTL2 Antibody Sales and Growth Rate (2017-2022)
Figure China EXTL2 Antibody Sales and Growth Rate (2017-2022)
Figure Japan EXTL2 Antibody Sales and Growth Rate (2017-2022)
Figure Southeast Asia EXTL2 Antibody Sales and Growth Rate (2017-2022)
Figure Other Regions EXTL2 Antibody Sales and Growth Rate (2017-2022)
Table Global EXTL2 Antibody Sales by Big Type (2017-2022)
Table Global EXTL2 Antibody Sales Market Share by Big Type (2017-2022)
Figure Global EXTL2 Antibody Sales Market Share by Big Type in 2019
Table Global EXTL2 Antibody Revenue by Big Type (2017-2022)
Table Global EXTL2 Antibody Revenue Market Share by Big Type (2017-2022)
Table Global EXTL2 Antibody Revenue Market Share by Big Type in 2019
Figure Global Above 90% Sales Growth Rate (2017-2022)
Figure Global Above 90% Price (2017-2022)
Figure Global Above 95% Sales Growth Rate (2017-2022)
Figure Global Above 95% Price (2017-2022)
Figure Global Above 99% Sales Growth Rate (2017-2022)
Figure Global Above 99% Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global EXTL2 Antibody Sales by Big Application (2017-2022)
Table Global EXTL2 Antibody Sales Market Share by Big Application (2017-2022)
Figure Global EXTL2 Antibody Sales Market Share by Big Application in 2019
Figure Global Biopharmaceutical Companies Sales Growth Rate (2017-2022)
Figure Global Hospitals Sales Growth Rate (2017-2022)
Figure Global Bioscience Research Institutions Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global EXTL2 Antibody Sales and Growth Rate (2022-2027)
Figure Global EXTL2 Antibody Revenue and Growth Rate (2022-2027)
Table Global EXTL2 Antibody Sales Forecast by Regions (2022-2027)
Table Global EXTL2 Antibody Market Share Forecast by Regions (2022-2027)
Figure North America Sales EXTL2 Antibody Market Forecast (2022-2027)
Figure Europe Sales EXTL2 Antibody Market Forecast (2022-2027)
Figure China Sales EXTL2 Antibody Market Forecast (2022-2027)
Figure Japan Sales EXTL2 Antibody Market Forecast (2022-2027)
Figure Southeast Asia Sales EXTL2 Antibody Market Forecast (2022-2027)
Figure Other Regions Sales EXTL2 Antibody Market Forecast (2022-2027)
Table Global EXTL2 Antibody Sales Forecast by Type (2022-2027)
Table Global EXTL2 Antibody Market Share Forecast by Type (2022-2027)
Table Global EXTL2 Antibody Sales Forecast by Application (2022-2027)
Table Global EXTL2 Antibody Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of EXTL2 Antibody
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America EXTL2 Antibody Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America EXTL2 Antibody Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe EXTL2 Antibody Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe EXTL2 Antibody Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan EXTL2 Antibody Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan EXTL2 Antibody Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China EXTL2 Antibody Production (K Units) Growth Rate Forecast (2021-2025)
Figure China EXTL2 Antibody Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
R&D Systems(US)
Novus Biologicals(US)
Biosave(UK)
Abcam(UK)
BosterBio(US)
Thermo Fisher Scientific(US)
Proteintech(US)
Atlas Antibodies(SE)
Funakoshi(JP)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)